108 related articles for article (PubMed ID: 3341783)
21. [What is safe in the therapy of advanced prostatic cancer?].
Gropp C; Burk K
Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
[No Abstract] [Full Text] [Related]
22. [Locally advanced prostate cancer: definition, prognosis and treatment].
Plantade A; Massard C; de Crevoisier R; Fizazi K
Bull Cancer; 2007 Jul; 94(7 Suppl):F50-61. PubMed ID: 17845994
[TBL] [Abstract][Full Text] [Related]
23. Treatment options in lymph node-positive prostate cancer.
Swanson GP; Thompson IM; Basler J
Cancer; 2006 Jun; 106(12):2531-9. PubMed ID: 16700035
[TBL] [Abstract][Full Text] [Related]
24. [Prostatic cancer--what to do?].
Bandhauer K
Schweiz Med Wochenschr; 1983 Sep; 113(36):1268-72. PubMed ID: 6635626
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study of prostatic cancer--statistical analysis of 184 cases in the latest 21 years].
Yamashita A; Hayashi N; Sugimura Y; Yanagawa M; Arima K; Nakano S; Kimbara H; Tochigi H; Kawamura J
Hinyokika Kiyo; 1995 Jun; 41(6):447-53. PubMed ID: 7645452
[TBL] [Abstract][Full Text] [Related]
26. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
Granfors T; Modig H; Damber JE; Tomic R
J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
[TBL] [Abstract][Full Text] [Related]
27. Radiation therapy of localized prostate cancer.
Landmann C
Ann Urol (Paris); 1994; 28(4):207-20. PubMed ID: 7979211
[TBL] [Abstract][Full Text] [Related]
28. [Clinical protocols in treatment of prostatic carcinoma in Europe. The role of EORTC and other organizations].
Newling DW
Urologe A; 1995 Sep; 34(5):374-81. PubMed ID: 7483153
[TBL] [Abstract][Full Text] [Related]
29. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
[TBL] [Abstract][Full Text] [Related]
30. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
[TBL] [Abstract][Full Text] [Related]
31. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
32. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
33. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
34. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
Mayer FJ; Crawford ED
Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
[TBL] [Abstract][Full Text] [Related]
35. [Neoadjuvant endocrine therapy in patients with locally advanced prostate cancer].
Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1996 Oct; 42(10):821-7. PubMed ID: 8951482
[TBL] [Abstract][Full Text] [Related]
36. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Messing EM
J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14532828
[No Abstract] [Full Text] [Related]
37. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.
Gjertson CK; Asher KP; Sclar JD; Goluboff ET; Olsson CA; Benson MC; McKiernan JM
Urology; 2007 Oct; 70(4):723-7. PubMed ID: 17991544
[TBL] [Abstract][Full Text] [Related]
38. [Prostate cancer].
Kawai T; Washizuka M; Takahashi T; Kusuyama H
Gan To Kagaku Ryoho; 1984 May; 11(5):999-1004. PubMed ID: 6202247
[TBL] [Abstract][Full Text] [Related]
39. [Proton hypophysectomy and subtotal body irradiation in combined treatment of stage IV prostate cancer].
Aleksandrov VP; Kondrat'eva EA; Karelin MI; Konnov BA; Zharinov GM; Metelev VV; Pecherskiĭ AV
Urologiia; 1999; (6):26-8. PubMed ID: 16859000
[No Abstract] [Full Text] [Related]
40. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]